What antimicrobial regimen is appropriate for treating a urinary infection that includes Candida (yeast) and one or more bacterial pathogens?

Treatment for Mixed Yeast and Bacterial Urinary Infection

You must treat the bacterial and fungal components separately with distinct antimicrobial agents, as no single antibiotic covers both yeast and bacteria. The approach depends on whether the patient is symptomatic and their risk factors for disseminated infection.

Initial Assessment and Risk Stratification

First, determine if the patient requires treatment at all. Asymptomatic candiduria does NOT require antifungal treatment unless the patient is high-risk 1, 2. High-risk patients include:

• Neutropenic patients
• Very low-birth-weight infants (<1500 g)
• Patients undergoing urologic procedures or manipulation
• Patients with urinary tract obstruction or indwelling catheters

For the bacterial component, treat based on standard UTI guidelines with culture-directed antibiotics 3.

Treatment Algorithm for Symptomatic Mixed Infection

For Bacterial Component:

• Obtain urine culture and susceptibility testing before initiating therapy
• Use standard antibiotics based on local resistance patterns and culture results
• Common first-line options include trimethoprim-sulfamethoxazole, nitrofurantoin, or fosfomycin for uncomplicated cystitis 3
• Duration: typically 3-7 days for uncomplicated cystitis, 7-14 days for pyelonephritis

For Candida Component (Symptomatic Cystitis):

First-line therapy:

• Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks for fluconazole-susceptible organisms 1
• This is a strong recommendation with moderate-quality evidence

Alternative regimens for fluconazole-resistant species:

• For C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR oral flucytosine 25 mg/kg four times daily for 7-10 days 1
• For C. krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1

For Candida Pyelonephritis:

• Oral fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks for susceptible organisms 1
• For resistant species, use amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days with or without flucytosine 1

Critical Source Control Measures

These interventions are as important as antimicrobial therapy:

1. Remove indwelling bladder catheters if feasible (strong recommendation) 1
2. Eliminate urinary tract obstruction (strong recommendation) 1
3. Replace or remove nephrostomy tubes/stents if present 1
4. Optimize glycemic control in diabetic patients 4

Special Considerations

Patients Undergoing Urologic Procedures:

Even if asymptomatic, treat prophylactically with:

• Oral fluconazole 400 mg (6 mg/kg) daily OR
• Amphotericin B deoxycholate 0.3-0.6 mg/kg daily
• Give for several days before AND after the procedure 1

Bladder Irrigation:

For fluconazole-resistant species (C. glabrata, C. krusei), consider amphotericin B deoxycholate bladder irrigation at 50 mg/L sterile water daily for 5 days as adjunctive therapy (weak recommendation) 1

Common Pitfalls to Avoid

1. Do not treat asymptomatic candiduria in low-risk patients—this leads to unnecessary antifungal exposure and potential resistance 2, 5
2. Do not assume a single broad-spectrum antibiotic will cover both pathogens—you need separate agents
3. Do not forget source control—removing catheters and relieving obstruction is often more important than antimicrobials alone
4. Do not use echinocandins for urinary candidiasis—they achieve poor urinary concentrations and are not recommended 1
5. Do not use azoles other than fluconazole—other azoles have minimal active drug excretion in urine 2

Duration Considerations

Recent evidence suggests shorter durations may be effective. One study found no difference in clinical success between 7 days versus 14 days of fluconazole for symptomatic Candida UTI 6. However, the IDSA guidelines still recommend 14 days as the standard duration 1, and this remains the safest approach until more robust data emerge.